Novartis Reduces Workforce by Hundreds; Novo’s Combined Diabetes Treatment Advances to Phase 3 Trials

Novartis Reduces Workforce by Hundreds; Novo’s Combined Diabetes Treatment Advances to Phase 3 Trials

Novartis Reduces Workforce by Hundreds; Novo’s Combined Diabetes Treatment Advances to Phase 3 Trials